Savant Capital, LLC Sage Therapeutics, Inc. Transaction History
Savant Capital, LLC
- $13.2 Billion
- Q1 2025
A detailed history of Savant Capital, LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Savant Capital, LLC holds 15,587 shares of SAGE stock, worth $103,030. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,587Holding current value
$103,030% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SAGE
# of Institutions
219Shares Held
51.6MCall Options Held
220KPut Options Held
312K-
Black Rock Inc. New York, NY5.22MShares$34.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$33.6 Million0.0% of portfolio
-
Madison Avenue Partners, LP New York, NY4.48MShares$29.6 Million4.6% of portfolio
-
Tig Advisors, LLC New York, NY2.73MShares$18.1 Million1.36% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.09MShares$13.8 Million0.02% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $393M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...